Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence

被引：32

作者：

Passamonti, Francesco ^{[1
]}

Rumi, Elisa

Elena, Chiara

Arcaini, Luca

Merli, Michele

Pascutto, Cristiana

Cazzola, Mario

Lazzarino, Mario

机构：

[1] Fdn IRCCS Policlin San Matteo, Dept Haematol Oncol, Div Haematol, Pavia, Italy

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 150卷 / 06期

关键词：

acute leukaemia; myelofibrosis; prognostic factors; transfusion; INTERNATIONAL WORKING GROUP; MYELOID METAPLASIA; SURVIVAL; DIAGNOSIS;

D O I：

10.1111/j.1365-2141.2010.08275.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：719 / 721

页数：3

共 10 条

[1] Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia:: results in 20 patients and review of the literature [J].

Cervantes, F ;

Alvarez-Larrán, A ;

Hernández-Boluda, JC ;

Sureda, A ;

Torrebadell, M ;

Montserrat, E .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (04) :399-403

[2] New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment [J].

Cervantes, Francisco ;

Dupriez, Brigitte ;

Pereira, Arturo ;

Passamonti, Francesco ;

Reilly, John T. ;

Morra, Enrica ;

Vannucchi, Alessandro M. ;

Mesa, Ruben A. ;

Demory, Jean-Loup ;

Barosi, Giovanni ;

Rumi, Elisa ;

Tefferi, Ayalew .

BLOOD, 2009, 113 (13) :2895-2901

[3] Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: A phase II trial [J].

Marchetti, M ;

Barosi, G ;

Balestri, F ;

Viarengo, G ;

Gentili, S ;

Barulli, S ;

Demory, JL ;

Ilariucci, F ;

Volpe, A ;

Bordessoule, D ;

Grossi, A ;

Le Bousse-Kerdiles, MC ;

Caenazzo, A ;

Pecci, A ;

Falcone, A ;

Broccia, G ;

Bendotti, C ;

Bauduer, F ;

Buccisano, F ;

Dupriez, B .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :424-431

[4] Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients [J].

Morel, Pierre ;

Duhamel, Alain ;

Hivert, Benedicte ;

Stalniekiewicz, Laure ;

Demory, Jean-Loup ;

Dupriez, Brigitte .

BLOOD, 2010, 115 (22) :4350-4355

[5] A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) [J].

Passamonti, Francesco ;

Cervantes, Francisco ;

Vannucchi, Alessandro Maria ;

Morra, Enrica ;

Rumi, Elisa ;

Pereira, Arturo ;

Guglielmelli, Paola ;

Pungolino, Ester ;

Caramella, Marianna ;

Maffioli, Margherita ;

Pascutto, Cristiana ;

Lazzarino, Mario ;

Cazzola, Mario ;

Tefferi, Ayalew .

BLOOD, 2010, 115 (09) :1703-1708

[6] Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelotibrosis: recommendations from an ad hoc international expert panel [J].

Tefferi, Ayalew ;

Thiele, Juergen ;

Orazi, Attilio ;

Kvasnicka, Hans Michael ;

Barbui, Tiziano ;

Hanson, Curtis A. ;

Barosi, Giovanni ;

Verstovsek, Srdan ;

Birgegard, Gunnar ;

Mesa, Ruben ;

Reilly, John T. ;

Gisslinger, Heinz ;

Vannucchi, Alessandro M. ;

Cervantes, Francisco ;

Finazzi, Guido ;

Hoffman, Ronald ;

Gilliland, D. Gary ;

Bloomfield, Clara D. ;

Vardiman, James W. .

BLOOD, 2007, 110 (04) :1092-1097

[7] Lenalidomide therapy in myelofibrosis with myeloid metaplasia [J].

Tefferi, Ayalew ;

Cortes, Jorge ;

Verstovsek, Srdan ;

Mesa, Ruben A. ;

Thomas, Deborah ;

Lasho, Terra L. ;

Hogan, William J. ;

Litzow, Mark R. ;

Allred, Jacob B. ;

Jones, Dan ;

Byrne, Catriona ;

Zeldis, Jerome B. ;

Ketterling, Rhett P. ;

McClure, Rebecca F. ;

Giles, Francis ;

Kantarjian, Hagop M. .

BLOOD, 2006, 108 (04) :1158-1164

[8] Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis-prognostic relevance is independent of IPSS or karyotype [J].

Tefferi, Ayalew ;

Siragusa, Sergio ;

Hussein, Kebede ;

Schwager, Susan M. ;

Hanson, Curtis A. ;

Pardanani, Animesh ;

Cervantes, Francisco ;

Passamonti, Francesco .

AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (01) :14-17

[9] Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis [J].

Tefferi, Ayalew ;

Verstovsek, Srdan ;

Barosi, Giovanni ;

Passamonti, Francesco ;

Roboz, Gail J. ;

Gisslinger, Heinz ;

Paquette, Ronald L. ;

Cervantes, Francisco ;

Rivera, Candido E. ;

Deeg, H. Joachim ;

Thiele, Juergen ;

Kvasnicka, Hans M. ;

Vardiman, James W. ;

Zhang, Yanming ;

Bekele, B. Nebiyou ;

Mesa, Ruben A. ;

Gale, Robert P. ;

Kantarjian, Hagop M. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4563-4569

[10] Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not [J].

Tefferi, Ayalew ;

Mesa, Ruben A. ;

Pardanani, Animesh ;

Hussein, Kebede ;

Schwager, Susan ;

Hanson, Curtis A. ;

Steensma, David P. .

AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (05) :265-267

← 1 →